Literature DB >> 32775330

Association Study of MTHFR Polymorphisms with Nonarteritic Anterior Ischemic Optic Neuropathy in a Spanish Population.

Beatriz Fernández-Vega1,2,3, Lydia Álvarez2, Montserrat García1,2, Enol Artime2, Marta Diñeiro Soto4, Javier Nicieza5, José A Vega3,6, Héctor González-Iglesias1,2.   

Abstract

INTRODUCTION: Nonarteritic anterior ischemic optic neuropathy (NAION), painless loss of central and/or peripheral vision, is a multifactorial disease caused by insufficient blood flow through the posterior ciliary arteries to the optic nerve head. Mutations in the methylenetetrahydrofolate reductase (MTHFR) gene, triggering hyperhomocysteinemia as a consequence of a decreased activity of the codified enzyme, have been considered to be among the risk factors of NAION.
OBJECTIVE: The main aim was to study the association of the most common MTHFR genetic polymorphisms C677T and A1298C with NAION in a Spanish population.
METHODS: In this case-control study, the association of the most common MTHFR polymorphisms was investigated in 94 unrelated native Spanish patients diagnosed with NAION and 204 healthy controls. Two single nucleotide polymorphisms located in the MTHFR gene, C677T (rs1801133) and A1298C (rs1801131), were analyzed by DNA sequencing and TaqMan assays.
RESULTS: The allelic and genotypic frequencies of the MTHFR variants obtained in the NAION group were not significantly different when compared with the control group. A higher frequency of the C677T/A1298C genotype, codifying the nonmutated MTHFR form, was obtained in control subjects (11.27%) compared to NAION patients (4.26%), suggesting a protective effect of the wild-type protein, although this result was not conclusive considering the obtained confidence interval (CI) (95% CI: 0.13-1.06). Study of additional clinical factors including hypertension, diabetes mellitus, and dyslipidemia showed no association with a higher risk of NAION. Conversely, the clinical history of heart or cerebrovascular diseases was significantly higher in NAION patients compared to controls. Over the world, risk variants of the MTHFR gene are highly frequent, excluding African black populations, indicating a racial influence.
CONCLUSIONS: The MTHFR variants did not significantly increase the risk of suffering from NAION. However, considering that individuals with at least one of the risk variants have the MTHFR enzyme with decreased activity, it cannot be ruled out that these mutations are relevant for the development of NAION in a subgroup of the population with other specific characteristics. These may include high plasma levels of homocysteine along with nutritional deficiencies including low folate or vitamin B12 and the combination of systemic and local risk factors.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  A1298C; Association study; C677T; Methylenetetrahydrofolate reductase gene; Nonarteritic anterior ischemic optic neuropathy

Year:  2020        PMID: 32775330      PMCID: PMC7383253          DOI: 10.1159/000505431

Source DB:  PubMed          Journal:  Biomed Hub        ISSN: 2296-6870


  53 in total

1.  Is non-arteritic anterior ischaemic optic neuropathy related to homocysteine?

Authors:  V Biousse; J B Kerrison; N J Newman
Journal:  Br J Ophthalmol       Date:  2000-05       Impact factor: 4.638

2.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

3.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

4.  Risk Factors for Non-arteritic Anterior Ischaemic Optic Neuropathy in a Korean Population.

Authors:  Dae Hyun Kim; Gwang Rae Shin; Young Je Choi
Journal:  Neuroophthalmology       Date:  2017-01-11

5.  Analysis of prothrombotic and vascular risk factors in patients with nonarteritic anterior ischemic optic neuropathy.

Authors:  O Salomon; R Huna-Baron; S Kurtz; D M Steinberg; J Moisseiev; N Rosenberg; I Yassur; O Vidne; A Zivelin; S Gitel; J Davidson; B Ravid; U Seligsohn
Journal:  Ophthalmology       Date:  1999-04       Impact factor: 12.079

6.  Nonarteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure.

Authors:  Raed Behbehani; Michaela K Mathews; Robert C Sergott; Peter J Savino
Journal:  Am J Ophthalmol       Date:  2005-03       Impact factor: 5.258

7.  Hyperhomocystinemia in patients with nonarteritic anterior ischemic optic neuropathy, central retinal artery occlusion, and central retinal vein occlusion.

Authors:  P Pianka; Y Almog; O Man; M Goldstein; B A Sela; A Loewenstein
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

8.  Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California.

Authors:  L N Johnson; A C Arnold
Journal:  J Neuroophthalmol       Date:  1994-03       Impact factor: 3.042

9.  Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuropathy: a case-control study.

Authors:  Barbara Giambene; Andrea Sodi; Francesco Sofi; Rossella Marcucci; Sandra Fedi; Rosanna Abbate; Domenico Prisco; Ugo Menchini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-04       Impact factor: 3.117

10.  Anterior ischemic optic neuropathy. VIII. Clinical features and pathogenesis of post-hemorrhagic amaurosis.

Authors:  S S Hayreh
Journal:  Ophthalmology       Date:  1987-11       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.